Charles Goodwin | President & Chief Executive Officer |
Tara Semb | Chief Financial Officer, Treasurer & Secretary |
Matthew Hewitt | Craig-Hallum Capital |
Hello, and welcome, ladies and gentlemen to the First Quarter of 2022 Earnings Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode. At the end of the company's prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on current expectations of management and involve inherent risks and uncertainties that can cause actual results to differ materially from those indicated, including, without limitation, those identified in the Risk Factors section of our recent annual report on Form 10-K, filed with the Securities and Exchange Commission, on our most recent 10-Q filing, and the company's other filings with the Securities and Exchange Commission.